Related Experiment Videos
Brucella melitensis infection in sheep: present and future
B Garin-Bastuji1, J M Blasco, M Grayon
1Laboratoire de référence OIE pour la brucellose, Maisons-Alfort, France. vaal20@calva.net
Veterinary Research
|August 5, 1998
Summary
Sheep brucellosis, caused by Brucella melitensis, is a global zoonotic disease. The live B. melitensis Rev 1 vaccine is effective for flock vaccination, significantly reducing disease prevalence in sheep and humans.
Area of Science:
- Veterinary Medicine
- Microbiology
- Zoonotic Diseases
Background:
- Sheep brucellosis, primarily caused by Brucella melitensis, is a significant zoonotic disease with global prevalence.
- The disease shares pathological and epidemiological similarities with Brucella abortus infection in cattle.
Purpose of the Study:
- To review current strategies for controlling sheep brucellosis.
- To evaluate diagnostic methods and vaccine efficacy for Brucella melitensis.
Main Methods:
- Review of literature on sheep brucellosis control, diagnosis, and vaccination.
- Analysis of diagnostic techniques including culture, PCR, serological tests (Rose Bengal plate agglutination, complement fixation, ELISA), and skin tests.
- Evaluation of the live B. melitensis Rev 1 vaccine efficacy.
Main Results:
- The live B. melitensis Rev 1 strain, administered conjunctivally, is highly effective for whole-flock vaccination, reducing disease prevalence in sheep and humans.
- Bacterial isolation and identification rely on selective media, biochemical tests, phage lysis, and increasingly, PCR-based methods for differentiation.
- Serological tests like Rose Bengal plate agglutination and complement fixation are recommended for screening, despite potential limitations in sensitivity and specificity.
Conclusions:
- Whole-flock vaccination with B. melitensis Rev 1 is a key strategy for sheep brucellosis control.
- A combination of diagnostic methods, including bacterial culture, PCR, and serological tests, is essential for accurate diagnosis and disease management.
- Test-and-slaughter strategies should be reserved for low-prevalence areas due to cost-effectiveness.